Standard InChI: InChI=1S/C27H32F2N8/c1-5-35-8-10-36(11-9-35)16-19-6-7-24(30-14-19)33-27-31-15-22(29)25(34-27)20-12-21(28)26-23(13-20)37(17(2)3)18(4)32-26/h6-7,12-15,17H,5,8-11,16H2,1-4H3,(H,30,31,33,34) (Source: PubChem)
PubChem CID: 46220502 (Source: PubChem)
SMILES String: CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F (Source: PubChem)
Standard InChIKey: UZWDCWONPYILKI-UHFFFAOYSA-N (Source: PubChem)
Connectivity SMILES string: CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F (Source: PubChem)
IUPAC Name: N-[5-[(4-ethylpiperazin-1-yl)methyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine (Source: PubChem)
ChEMBL ID: CHEMBL3301610 (Source: PubChem)
CAS Registry Number: 1231929-97-7 (Source: PubChem)
CompTox Dashboard Substance ID: DTXSID20673119 (Source: PubChem)
European Community Number: 806-670-8 (Source: PubChem)
Wikidata ID: Q23901483 (Source: PubChem)
ChEBI ID: CHEBI:233362 (Source: PubChem)
Preferred Name: ABEMACICLIB (Source: ChEMBL)
WHO ATC Classification Drug Code: L01EF03 (Source: ChEMBL)
WHO ATC Classification Drug Name: Abemaciclib (Source: ChEMBL)
British National Formulary: Abemaciclib (Source: ChEMBL)
European Medicines Agency Name: Abemaciclib (Source: ChEMBL)
International Nonproprietary Name: Abemaciclib (Source: ChEMBL)
Japanese Adopted Name: Abemaciclib (Source: ChEMBL)
Merck Index Name: Abemaciclib (Source: ChEMBL)
US Adopted Name: Abemaciclib (Source: ChEMBL)
Standard InChI: InChI=1S/C27H32F2N8/c1-5-35-8-10-36(11-9-35)16-19-6-7-24(30-14-19)33-27-31-15-22(29)25(34-27)20-12-21(28)26-23(13-20)37(17(2)3)18(4)32-26/h6-7,12-15,17H,5,8-11,16H2,1-4H3,(H,30,31,33,34) (Source: ChEMBL)
Standard InChIKey: UZWDCWONPYILKI-UHFFFAOYSA-N (Source: ChEMBL)
Connectivity SMILES string: CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1 (Source: ChEMBL)